Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|July 28, 2022
Analysis of FDA's Accelerated Approval Program Performance December 1992-December 2021Ginny Beakes-Read, Madison Neisser, Patrick Frey, et al.
Therapeutic Innovation & Regulatory Science|June 2, 2023
Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future-An Industry ViewGaia Geraci, Janis Bernat, Céline Rodier, et al.
Frontiers in Medicine|August 11, 2023
Walking the talk in digital transformation of regulatory reviewRamy Khalil, Judith C Macdonald, Andrew Gustafson, et al.
International Journal of Molecular Sciences|June 26, 2025
Uncovering the Distinct Role of Phleum p 4 in Grass Pollen Allergy: Sensitization Patterns in 1963 Swiss PatientsPatrick Frey, Phil Cheng, Peter Schmid-Grendelmeier, et al.
Cancers|April 25, 2020
Canonical BMP Signaling Executes Epithelial-Mesenchymal Transition Downstream of SNAIL1Patrick Frey, Antoine Devisme, Monika Schrempp, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 7, 2024
[Implementation of reference frameworks at nursing schools - A qualitative study on beneficial and hindering factors]Bärbel Wesselborg, Astrid Stephan, Patrick Frey, et al.
Oncogene|December 3, 2021
SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancerPatrick Frey, Antoine Devisme, Katja Rose, et al.
International Journal of Cancer|August 30, 2019
SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferationVivien Freihen, Kerstin Rönsch, Justin Mastroianni, et al.
Biochimica Et Biophysica Acta|August 10, 2016
Enhancer decommissioning by Snail1-induced competitive displacement of TCF7L2 and down-regulation of transcriptional activators results in EPHB2 silencingOskar Schnappauf, Sven Beyes, Annika Dertmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2025
Analytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With an FDA-Approved BenchmarkSunil Badve, Jason S White, Francisco Sapunar, et al.
Pageof 2